Screener
NRX Pharmaceuticals, Inc. NRXP Q3 2025 earnings
Reported November 14, 2025 · Before market open
Revenue$242.0KMiss by $7.3M
EPS-$0.18Miss by $0.07
Revenue estimate$7.5M
EPS estimate-$0.11
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.3M
EPS estimate-$0.26
Versus estimates
Revenue
Diluted EPS
FAQ
- When did NRX Pharmaceuticals, Inc. report Q3 2025 earnings?
- NRX Pharmaceuticals, Inc. (NRXP) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were NRX Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- NRX Pharmaceuticals, Inc. reported revenue of $242.0K and eps of $-0.18 for Q3 2025.
- Did NRX Pharmaceuticals, Inc. beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $7.5M by $7.3M. EPS missed the consensus estimate of $-0.11 by $0.07.
- How did NRX Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 20.0% from $-0.15.
- Where can I find NRX Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-035210) directly on SEC EDGAR. The filing index links above go to sec.gov.
